USANA Health Sciences Inc. has entered into a Third Amended and Restated Credit Agreement with Bank of America, N.A., as well as other lenders, effective June 27, 2025. This agreement provides USANA with a revolving credit facility up to $75 million, with an option to increase the commitment by an additional $200 million, subject to certain conditions. The agreement involves a pledge of capital stock from USANA's subsidiaries as security and outlines various interest rates depending on the type of loan. In the event of default, Bank of America holds the right to demand immediate repayment and terminate any future loan commitments. This strategic financial arrangement aims to bolster USANA's liquidity and operational flexibility.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.